Newton Biocapital
Brusselsnewtonbiocapital.com
Overview
Newton Biocapital is a venture capital firm that invests in early-stage biotech and life science companies in Europe and Japan, with a focus on finding solutions for chronic diseases.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Bioxodes | Dec 2025 | Series B | Lead |
| EPICS Therapeutics | Sep 2025 | VC Round | Lead |
| Augustine Therapeutics | Mar 2025 | Series A | Co-investor |
| EPICS Therapeutics | Oct 2024 | Series A Extension | Lead |
| AbolerIS Pharma | Sep 2023 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
